Two Yields, One SPYI ETF: 12% for the Marketing, 0.47% for the SEC
SPYI publishes two yield figures that look like they belong to completely different funds, and both are calculated correctly. Understanding…
SPYI publishes two yield figures that look like they belong to completely different funds, and both are calculated correctly. Understanding…
Nebius Group built one of the year's most impressive AI cloud runs, then dropped double digits in a single morning.…
Michael Burry is betting that one of the hottest AI stocks on the market will lose virtually all of its…
Agency mortgage REITs dangle double-digit monthly yields backed by government-guaranteed bonds, but leverage cuts both ways and two of these…
Treasury yields just hit a 19-year high, making dividend stocks look like a losing bet on paper. What actually happened…
Anthropic just posted numbers that made OpenAI's growth look slow, and now it wants a $2 trillion valuation at IPO.…
SanDisk just posted one of the most violent stock runs in large-cap history, yet institutional investors are betting against each…
Daniel Sundheim built a position in SpaceX so large it dwarfs every other holding in D1 Capital's book, and the…
Brad Gerstner just placed some of his biggest bets of the year during one of the choppiest quarters for tech…
GM's relentless buyback machine crushed Ford and the S&P 500 for over a year, but something shifted in 2026 and…
Most retirees scrambling to cover missed quarterly tax payments assume they have run out of options by December, but the…
A massive warrant disclosure just reshuffled who builds Google's AI chips, sending one semiconductor giant surging while punishing the longtime…
Eli Lilly just became the first pharmaceutical company ever valued above $1 trillion, yet analysts who dig into its pipeline…
SK Hynix just approved the largest treasury share cancellation in South Korean stock market history, and the move is pulling…
AI data centers are quietly reshaping who profits from the natural gas boom, and it has nothing to do with…
A single Phase 3 readout just shook the cancer treatment world, sending one biotech stock to its biggest single-day gain…
With volatility near a 12-month low, the premium that SPYI, JEPQ, and GPIQ convert into monthly cash has shrunk, and…
A seven-week trial against Meta carries a headline damages figure that most investors are anchoring to for the wrong reasons,…
Not all mortgage REITs offering double-digit yields are running the same play, and confusing one for another right now carries…
Home Depot's stock sits well below its 52-week high after a rough stretch, but something in the latest earnings report…